Mesoblast (MESO) Income from Continuing Operations (2016 - 2023)
Historic Income from Continuing Operations for Mesoblast (MESO) over the last 9 years, with Q2 2023 value amounting to -$22.0 million.
- Mesoblast's Income from Continuing Operations fell 56.79% to -$22.0 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$82.2 million, marking a year-over-year increase of 1068.55%. This contributed to the annual value of -$102.1 million for FY2025, which is 1612.85% down from last year.
- As of Q2 2023, Mesoblast's Income from Continuing Operations stood at -$22.0 million, which was down 56.79% from -$18.6 million recorded in Q1 2023.
- Mesoblast's 5-year Income from Continuing Operations high stood at -$7.4 million for Q3 2019, and its period low was -$29.4 million during Q1 2019.
- Moreover, its 5-year median value for Income from Continuing Operations was -$22.4 million (2021), whereas its average is -$22.5 million.
- Per our database at Business Quant, Mesoblast's Income from Continuing Operations skyrocketed by 6455.07% in 2019 and then crashed by 25064.72% in 2020.
- Mesoblast's Income from Continuing Operations (Quarter) stood at -$29.1 million in 2019, then increased by 12.29% to -$25.5 million in 2020, then fell by 2.2% to -$26.1 million in 2021, then increased by 5.66% to -$24.6 million in 2022, then rose by 10.84% to -$22.0 million in 2023.
- Its Income from Continuing Operations was -$22.0 million in Q2 2023, compared to -$18.6 million in Q1 2023 and -$24.6 million in Q4 2022.